Droplette

About:

Droplette is a needle-free and hand-held device that delivers large molecules deep through skin.

Website: https://droplette.io/

Twitter/X: droplettedevice

Top Investors: Alumni Ventures, K5 Global, Spark Capital, Bolt, Bantam Group

Description:

Droplette is their patent-pending transdermal delivery system for delivery of drugs up to 60% larger than current treatments deep into skin over large surface areas. Their unique device is painless, contact free, portable and generates no disposables. It is designed to deliver antibiotics for serious ulcers and skin infections, reducing risk secondary complications or antibiotic resistance. Future applications include localized delivery of chemotherapeutics for skin cancer and drugs for anti-aging.

Total Funding Amount:

$21M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)thedroplette.com

Founders:

Madhavi Gavini, Rathi Srinivas

Number of Employees:

11-50

Last Funding Date:

2024-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai